Artal Group’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Artal Group’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,500	Closed	-$1.22M	–	142
2022 Q3	$1.22M	Hold	28,500	–	–	0.05%	107
2022 Q2	$1.45M	Hold	28,500	–	–	0.08%	109
2022 Q1	$1.83M	Hold	28,500	–	–	0.08%	115
2021 Q4	$1.49M	Hold	28,500	–	–	0.04%	133
2021 Q3	$2.12M	Hold	28,500	–	–	0.05%	135
2021 Q2	$2.86M	Hold	28,500	–	–	0.06%	131
2021 Q1	$3.39M	Hold	28,500	–	–	0.06%	130
2020 Q4	$3.7M	Hold	28,500	–	–	0.08%	112
2020 Q3	$3.29M	Sell	28,500 -7,500	-21%	-$924K	0.08%	112
2020 Q2	$4.98M	Buy	36,000 +12,000	+50%	+$1.47M	0.14%	107
2020 Q1	$2.05M	Buy	24,000 +6,000	+33%	+$615K	0.09%	97
2019 Q4	$1.8M	Hold	18,000	–	–	0.07%	94
2019 Q3	$2.55M	Buy	18,000 +2,410	+15%	+$446K	0.1%	92
2019 Q2	$3.63M	Buy	+15,590	New	+$4.94M	0.15%	89

Other funds holding AXLA

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

ZIM

Zacks Investment Management Chicago, Illinois $14.1B AUM 39.89% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Artal Group's AXLA Position: Q4 2022 in Review

Artal Group sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2022, closing a stake of 28,500 shares — an estimated $1.22M sold.

Artal Group first reported a position in AXLA in Q2 2019 and held it in 14 quarters. The position peaked at $4.98M in Q2 2020. 34 funds tracked by Wall St. Rank hold AXLA as of Q4 2022.

Artal Group reported no remaining Axcella Health Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Artal Group sold 28,500 Axcella Health Inc. Common Stock shares in Q4 2022, an estimated $1.22M.
Artal Group first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 14 quarters.
Artal Group's Axcella Health Inc. Common Stock position peaked at $4.98M in Q2 2020.
34 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2022.

Based on Artal Group's 13F filing for Q4 2022, filed 13 Feb 2023.